150 related articles for article (PubMed ID: 1325358)
21. The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects.
Freye E; Latasch L; Portoghese PS
Eur J Anaesthesiol; 1992 Nov; 9(6):457-62. PubMed ID: 1330549
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
Steinmiller CL; Young AM
Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
[TBL] [Abstract][Full Text] [Related]
23. A lack of potency for the delta-opioid antagonist naltrindole after microinjection into the rostral ventrolateral medulla of rabbits.
Morilak D; Drolet G; Chalmers J
Clin Exp Pharmacol Physiol; 1990 Jul; 17(7):527-30. PubMed ID: 2169364
[TBL] [Abstract][Full Text] [Related]
24. Effects of naltrindole and nor-binaltorphimine treatment on antinociception induced by sub-acute selective mu opioid receptor blockade.
Walker MJ; Le AD; Poulos CX
Brain Res; 1992 Dec; 599(2):204-8. PubMed ID: 1337857
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE
J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
[TBL] [Abstract][Full Text] [Related]
26. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
27. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
Malmberg AB; Yaksh TL
J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
[TBL] [Abstract][Full Text] [Related]
28. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
29. Involvement of beta2-adrenergic and mu-opioid receptors in antinociception produced by intracerebroventricular administration of alpha,beta-methylene-ATP.
Fukui M; Nakagawa T; Minami M; Satoh M
Jpn J Pharmacol; 2001 Aug; 86(4):423-8. PubMed ID: 11569616
[TBL] [Abstract][Full Text] [Related]
30. Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors.
Goodchild CS; Guo Z; Musgreave A; Gent JP
Br J Anaesth; 1996 Dec; 77(6):758-63. PubMed ID: 9014630
[TBL] [Abstract][Full Text] [Related]
31. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
[TBL] [Abstract][Full Text] [Related]
32. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
33. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
Pick CG; Paul D; Pasternak GW
J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
[TBL] [Abstract][Full Text] [Related]
34. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
35. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
36. Relative contribution of peripheral versus central opioid receptors to antinociception.
Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
[TBL] [Abstract][Full Text] [Related]
37. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
Watkins LR; Wiertelak EP; Maier SF
Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
[TBL] [Abstract][Full Text] [Related]
38. Opioid receptors and acetaminophen (paracetamol).
Raffa RB; Walker EA; Sterious SN
Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
[TBL] [Abstract][Full Text] [Related]
39. Hypothermic effect of D-Ala-deltorphin II, a selective delta opioid receptor agonist.
Broccardo M; Improta G
Neurosci Lett; 1992 May; 139(2):209-12. PubMed ID: 1319015
[TBL] [Abstract][Full Text] [Related]
40. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
